Corpus Intelligence IC Memo — ST. LUKES SOUTH 2026-04-26 04:02 UTC
IC Memo — ST. LUKES SOUTH
Investment Committee Memorandum | KS | 91 beds | Grade C | EBITDA uplift $16.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ST. LUKES SOUTH

CCN 170185 | JOHNSON, KS | 91 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ST. LUKES SOUTH is a 91-bed suburban community hospital in JOHNSON, KS with $218.2M in net patient revenue and a -13.1% operating margin. The hospital serves a payer mix of 40.5% Medicare, 2.4% Medicaid, and 57.2% commercial.

Thesis: Turnaround. Our ML models identify $16.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -13.1% to -5.8% (+736bps).

Net Revenue HCRIS$218.2M
Current EBITDA COMPUTED$-28.7M
Operating Margin COMPUTED-13.1%
Occupancy HCRIS54.9%
Revenue / Bed COMPUTED$2.4M
Net-to-Gross HCRIS21.1%
Distress Probability ML44.3%

2. Market Context & Competitive Position

152
KS Hospitals
-17.7%
State Median Margin
26
Comparable Hospitals

KS has 152 Medicare-certified hospitals with a median operating margin of -17.7%. The target's margin of -13.1% places it above the state median. Among 26 size-comparable peers (46-182 beds), the median margin is -7.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (46-182), prioritizing same-state peers. 26 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ST. LUKES SOUTH (Target)KS91$218.2M-13.1%
LAWRENCE MEMORIAL HOSPITALKS110$346.7M-4.0%
AM 1 MENORAH MEDICAL CENTERKS137$289.4M8.5%
SALINA REGIONAL HEALTH CENTERKS177$226.7M-39.5%
HAYS MEDICAL CENTER INC.KS136$215.1M-12.3%
HUTCHINSON REGIONAL MEDICAL CEKS147$132.3M-50.0%
PROVIDENCE MEDICAL CENTERKS176$107.7M-15.3%
CENTURA ST. CATHERINE - GARDENKS90$107.1M-8.1%
MERCY REGIONAL HEALTH CENTERKS84$95.8M0.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $16.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.6M+210bp18mo
Cost to Collect4.5%2.5%$4.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.7M+122bp9mo
Clean Claim Rate88.0%96.0%$140K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.6M
Cost to Collect
$4.4M
Denial Rate Reduction
$4.3M
A/R Days Reduction
$2.7M
Clean Claim Rate
$140K
Total EBITDA Uplift$16.1M
Current EBITDA$-28.7M
+ RCM Uplift+$16.1M
Pro Forma EBITDA$-12.6M
Current Margin-13.1%
Pro Forma Margin-5.8%
WC Released (1x)$8.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-44.1M$-28.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-44.1M$-45.7M0.00x-100.0%
Bull Case9.0x11.0x$-39.7M$-7.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-39.7M$-19.3M0.00x-100.0%
Bear Case11.0x10.0x$-48.5M$-94.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-48.5M$-119.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 26 hospitals with 46-182 beds
  • Same-state prioritization (n=27)
  • Comp margins: P25=-18.8% / P50=-7.9% / P75=0.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.